Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00542854
Other study ID # CHB-07-08-0308
Secondary ID
Status Completed
Phase N/A
First received October 10, 2007
Last updated January 27, 2009
Start date October 2007
Est. completion date September 2008

Study information

Verified date January 2009
Source Children's Hospital Boston
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Unlike phones, which are commonly held to the ear, music is now available via portable MP3 players and they can be held almost anywhere. Thaker et al state that Apple iPods cause pacemaker interference in 50% of their patients, with over-sensing in 20% of patients, telemetry interference in 29% of patients and pacemaker inhibition in 1.2% of patients. The mean age for their sample was 76.1 years +/- 8.6 years. We anticipate that a higher proportion of teenagers and children who have pacemakers use portable MP3 players than in the elderly adult population.We will include the first 100 patients with pacemakers and ICDs who consent for the prospective observational study a single tertiary care center. We intend to conduct a descriptive study, tabulating the number of times that a pacemaker or ICD has changes in the sensing thresholds, pacing thresholds, telemetry interference or pacemaker inhibition when exposed to a series of portable MP3 players at various distances. In addition, we will describe the nature and quantitative differences of those changes.


Description:

Since pacemakers and implantable cardioverter defibrillators (ICDs) have been used, there have been questions about what external sources interference could alter their functioning or event recording properties. Because these devices are often intended to be life-saving, their proper functioning is of critical importance.

The literature documents a number of common sources of possible interference. Interference with MRI and electrocautery have been observed (1, 2). Outside the hospital, store security devices and personal digital assistants (PDAs) have been evaluated (3, 4). In 1997, Hayes et al published a randomized, prospective trial concluding that cellular telephones impacted the functioning of pacemakers, but that they did not seem to have any effect at any significant distance (5). They showed that a phone being used at the ear was sufficiently far away to prevent a health risk and recommended that phones not be put in shirt pockets or used near the device.

Unlike phones, which are commonly held to the ear, music is now available via portable MP3 players and they can be held almost anywhere. Thaker et al state that Apple iPods cause pacemaker interference in 50% of their patients, with over-sensing in 20% of patients, telemetry interference in 29% of patients and pacemaker inhibition in 1.2% of patients (6). The mean age for their sample was 76.1 years +/- 8.6 years. We anticipate that a higher proportion of teenagers and kids who have pacemakers use portable MP3 players than in the elderly adult population.

Design Prospective observational study a single tertiary care center.

Subjects

The electrophysiology department at Children's Hospital, Boston follows a large number of patients with pacemakers and ICDs. Approximately 15 patients are seen each week in clinic for routine pacemaker evaluation.

Entry Criteria We will include the first 100 patients with pacemakers and ICDs who consent for the prospective trial.

1. Consent for participation

2. Active pacemaker/ICD, which is functioning appropriately at the time of interrogation based on internal diagnostics and the judgment of an appropriate clinician (electrophysiology nurse, fellow and/or attending.

3. Normally functioning leads and thresholds at the time of interrogation based on internal diagnostics and the judgment of an appropriate clinician (electrophysiology nurse, fellow and/or attending.

Variables

Primary Outcome Change in pacemaker sensing thresholds, pacing thresholds, telemetry interference or pacemaker inhibition.

Methods

Study investigators will first obtain informed consent from each patient or family and, where appropriate, assent from the child.

At the conclusion of their routine clinic visit, each patient will have his or her pacemaker attached to the appropriate proprietary interrogation system for their pacemaker device. We will then monitor the pacemaker/ICD system while placing a series of portable music devices at various distances from the pacemaker/ICD system: (1) 2cm, (2) 30cm, (3) 100cm. At each distance the pacemaker will be re-interrogated for changes in pacemaker sensing thresholds, pacing thresholds, telemetry interference or pacemaker inhibition. At the end of the testing process, the devices will be removed from near the patient and the device will be interrogated again to assure that the device is at the appropriate clinical settings.

Risks

We believe that there are no more than minimal risks associated with this study. The principle intervention is the placement of a music device near the pacemaker/ICD during the time of pacemaker monitoring. We consider this risk to be similar to the risks encountered by many patients who are currently using portable music devices outside the hospital. In addition, we do not expect any permanent change in the pacemaker or ICD settings, thresholds or functioning.

Statistical Issues

Hypothesis Our hypothesis is that the close approximation of portable MP3 players interfere with the appropriate sensing and recording of pacemakers and ICDs.

Sample Size and Power Calculations We intend to conduct a descriptive study, tabulating the number of times that a pacemaker or ICD has changes in the sensing thresholds, pacing thresholds, telemetry interference or pacemaker inhibition when exposed to a series of portable MP3 players at various distances. In addition, we will describe the nature and quantitative differences of those changes.

Because we do not intend to do comparisons for significance against a control group, we have chosen 100 patients as a reasonable sample size for evaluating possible changes in pacemaker/ICD function.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date September 2008
Est. primary completion date September 2008
Accepts healthy volunteers No
Gender Both
Age group 4 Years to 55 Years
Eligibility Inclusion Criteria:

- Children and adults with congenital heart disease who have an implanted pacemaker or defibrillator

Exclusion Criteria:

- Age less than 4 or inability to communicate adequately with study team

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
MP3
4 different brands of MP3 players will be tested at 3 distances from ICD/pacemaker site in children and adults with congenital heart disease.

Locations

Country Name City State
United States Children's Hospital Boston Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital Boston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pacemaker sensing thresholds, pacing thresholds, telemetry interference or pacemaker inhibition. 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05048602 - Drug-induced Brugada Syndrome Research Database
Completed NCT05053243 - Clinical Validation of the AliveCor Kardia 12L and 6L Devices N/A
Completed NCT01913561 - The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection N/A
Completed NCT01688648 - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft N/A
Completed NCT01396226 - A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients Phase 2
Terminated NCT00624520 - Mental Stress Reduction in Defibrillator Patients Phase 3
Terminated NCT00721149 - NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study Phase 3
Completed NCT00756886 - Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study N/A
Completed NCT00510029 - Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously Phase 1
Completed NCT00578617 - Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial N/A
Active, not recruiting NCT00135174 - Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study N/A
Completed NCT00119847 - Electrophysiological Effects of Late PCI After MI N/A
Completed NCT00035490 - Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators Phase 3
Completed NCT00023556 - Genetic Architecture of Heart Disease in Rural Brazil N/A
Completed NCT01076361 - Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study N/A
Completed NCT00004560 - Public Access Defibrillation (PAD) Community Trial Phase 3
Recruiting NCT00138931 - Genetics of Cardiovascular and Neuromuscular Disease
Completed NCT00622453 - Arrhythmias in Myotonic Muscular Dystrophy N/A
Completed NCT01076348 - Model 4965 Post-Approval Study
Completed NCT00000531 - Antiarrhythmics Versus Implantable Defibrillators (AVID) Phase 3